BPC‑157 is a 15‑amino‑acid peptide originally found in stomach gastric juices and reproduced synthetically to match the body’s natural molecule. Dr. Jason Schuster highlights its remarkable ability to promote tissue repair, neuroregeneration, and angiogenesis while maintaining an exceptionally high safety profile.
A Lab‑Made Copy of a Natural Gut Peptide
BPC‑157 (Body‑Protective Compound‑157) is a synthetic formulation of a peptide naturally produced by the gut’s microbiome. Although it is manufactured in a lab, its molecular structure is identical to the endogenous peptide that our bodies have used for millennia.
How the Peptide Triggers Healing
According to Dr. Schuster, BPC‑157 up‑regulates Vascular Endothelial Growth Factor (VEGF), spurring angiogenesis, tissue remodeling, and neuronal regrowth. Animal studies show it can reverse microscopic damage after spinal‑cord or brain injury and promote wound closure.
- Increases VEGF → new blood vessel formation
- Stimulates nerve fiber regeneration
- Reduces inflammation in injured tissue
- Supports collagen synthesis and tendon repair
What Users May Experience
In the video Dr. Schuster cites multiple animal studies where BPC‑157 produced rapid recovery of musculoskeletal injuries, enhanced healing after laminotomies, and potential neuroprotective effects for concussions and spinal‑cord trauma. He also notes its similarity to human growth hormone without the associated adverse effects.
- Accelerated muscle, tendon, and ligament healing
- Improved recovery from spinal‑cord and brain injuries
- Potential anti‑cancer activity in pre‑clinical models
- Minimal reported side‑effects compared with conventional drugs
Typical Regimen and Precautions
The protocol discussed by Dr. Schuster recommends sub‑cutaneous injections of 5 mg (0.005 g) two to three times per week on an 8‑weeks‑on/8‑weeks‑off schedule. The reported lethal dose in animal studies is about 2 g per kilogram of body weight—roughly 136 g for a 150‑lb person—making the therapeutic dose over 27,000‑times lower.
- 5 mg injection, 2–3×/week
- Cycle: 8 weeks on, 8 weeks off
- Lethal dose ≈ 136 g for a 150 lb adult (≈27,000× therapeutic dose)
- Caution: may stimulate VEGF‑driven tumor growth; consult a specialist if cancer is present
“BPC‑157 seems to have much longer lasting effects than growth hormone without any of the negative lethal things.”— Dr. Jason Schuster
Dr. Schuster's short takes on this topic — tap to play.
Go deeper than the summary
Dr. Schuster's accredited courses on supplementation, epigenetics, and peptide therapy — the full research, dosing, and video breakdowns.